Company: Obagi Medical
[1]Starting stock price: $9.85
Ending stock price: $18.33
Percent Change: 86.09%
Details: Obagi Medical Products has developed prescription-strength skin health systems focused on preventing and/or improving skin conditions including photodamage, hyperpigmentation (chloasma, melasma, freckles), acne, vulgaris and rosacea. The company went public in October 2007.
Links:
[1] http://www.obagi.com/article/homepage.html
[2] http://www.fiercepharma.com/special-reports/chelsea-therapeutics-best-pharma-stocks-2007
[3] http://www.fiercepharma.com/special-reports/best-pharma-stocks-2007
[4] http://www.fiercepharma.com/special-reports/cleveland-biolabs-best-pharma-stocks-2007